The debilitating symptoms of obsessive-compulsive disorder impact the day-to-day functioning of as many as one in 200 ...
This article delves into the misconceptions surrounding mental illness and the urgent need for empathy and understanding.
Scientists may have discovered the first therapy for Huntington’s disease, a brain disorder that until now has had no effective treatments. Researchers at the University of College London (UCL) ...
The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or alcoholism, is widespread in many countries worldwide. Individuals diagnosed ...
Targeted radiation therapy might be a safer way to treat a potentially dangerous heart rate problem, a new study says. Radiation therapy treated ventricular tachycardia as well as a standard but ...
The end of pandemic-era enrollment enhancements for Medicaid was associated with a rise in the number of people ending medication treatment for opioid use disorder, as well as a decrease in the number ...
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...
Walker Burger always loved baseball, but attending the games of his favorite team, the Atlanta Braves, used to be a physical challenge. In fact, every form of exercise was difficult. Burger, 35, has a ...
Sept 19 (Reuters) - Regeneron (REGN.O), opens new tab said on Friday its experimental therapy showed either a complete or partial disappearance of a precancerous disorder, which manifests into blood ...
MORRISTOWN, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health ...
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). Bretisilocin is ...